Neuroinflammation and excitotoxicity in neurobiology of HIV-1 infection and AIDS: Targets for neuroprotection

Interaction Between Neurons and Glia in Aging and Disease

Volumn , Issue , 2007, Pages 281-308

  Kaul, Marcus ^a   Lipton, Stuart A ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79956071316     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-70830-0_13     Document Type: Chapter

References (216)

1. Adamson, D.C., Wildemann, B., Sasaki, M., Glass, J.D., McArthur, J.C., Christov, V.I., Dawson, T.M. and Dawson, V.L., 1996, Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274: 1917.
2. Adle-Biassette, H., Levy, Y., Colombel, M., Poron, F., Natchev, S., Keohane, C. and Gray, F., 1995, Neuronal apoptosis in HIV infection in adults. Neuropathol. Appl. Neurobiol. 21: 218.
3. Adle-Biassette, H., Chretien, F., Wingertsmann, L., Hery, C., Ereau, T., Scaravilli, F., Tardieu, M. and Gray, F., 1999, Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 25: 123.
4. Aizenman, E., Stout, A.K., Hartnett, K.A., Dineley, K.E., McLaughlin, B. and Reynolds, I.J., 2000, Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular Zinc release. J. Neurochem. 75: 1878.
5. Alkhatib, G., Combadiere, C., Broder, C.C., Feng, Y., Kennedy, P.E., Murphy, P.M. and Berger, E.A., 1996, CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955.
6. Anderson, E.R., Gendelman, H.E. and Xiong, H., 2004, Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis. J. Neurosci. 24: 7194.
7. Asensio, V.C. and Campbell, I.L., 1999, Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 22: 504.
8. Batchelor, P.E., Liberatore, G.T., Wong, J.Y., Porritt, M.J., Frerichs, F., Donnan, G.A. and Howells, D.W., 1999, Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19: 1708.
9. Bazan, J.F., Bacon, K.B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D.R., Zlotnik, A. and Schall, T.J., 1997, A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640.
10. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. and Freeman, B.A., 1990, Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620.
11. Bezzi, P., Carmignoto, G., Pasti, L., Vesce, S., Rossi, D., Rizzini, B.L., Pozzan, T. and Volterra, A., 1998, Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391: 281.
12. Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J. and Volterra, A., 2001, CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4: 702.
13. Bigge, C.F., 1999, Ionotropic glutamate receptors. Curr. Opin. Chem. Biol. 3: 441.
14. Bleul, C.C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. and Springer, T.A., 1996, The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382: 829.
15. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P. and Lipton, S.A., 1995, Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92: 7162.
16. Bormann, J., 1989, Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur. J. Pharmacol. 166: 591.
17. Brack-Werner, R. and Bell, J.E., 1999, Replication of HIV-1 in human astrocytes. Science Online: NeuroAids (www. sciencemag. org/NAIDS) 2: 1.
18. Brauner-Osborne, H., Egebjerg, J., Nielsen, E.O., Madsen, U. and Krogsgaard-Larsen, P., 2000, Ligands for glutamate receptors: design and therapeutic prospects. J. Med. Chem. 43: 2609.
19. Brenneman, D.E., Westbrook, G.L., Fitzgerald, S.P., Ennist, D.L., Elkins, K.L., Ruff, M.R. and Pert, C.B., 1988, Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639.
20. Brew, B.J., Corbeil, J., Pemberton, L., Evans, L., Saito, K., Penny, R., Cooper, D.A. and Heyes, M.P., 1995, Quinolinic acid production is related to macrophage tropic isolates of HIV-1. J. Neurovirol. 1: 369.
21. Bruno, V., Copani, A., Besong, G., Scoto, G. and Nicoletti, F., 2000, Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur. J. Pharmacol. 399: 117.
22. Budd, S.L., Tenneti, L., Lishnak, T. and Lipton, S.A., 2000, Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl. Acad. Sci. USA 97: 6161.
23. Budka, H., 1991, Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1: 163.
24. Chakravarty, S. and Herkenham, M., 2005, Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 25: 1788.
25. Chao, C.C., Hu, S., Sheng, W.S. and Peterson, P.K., 1995, Tumor necrosis factor-alpha production by human fetal microglial cells: regulation by other cytokines. Dev. Neurosci. 17: 97.
26. Chen, H.S. and Lipton, S.A., 1997, Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J. Physiol. 499: 27.
27. Chen, H.S., Pellegrini, J.W., Aggarwal, S.K., Lei, S.Z., Warach, S., Jensen, F.E. and Lipton, S.A., 1992, Openchannel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci. 12: 4427.
28. Chen, H.S., Wang, Y.F., Rayudu, P.V., Edgecomb, P., Neill, J.C., Segal, M.M., Lipton, S.A. and Jensen, F.E., 1998, Neuroprotective concentrations of the N-methyl-D-aspartate open- channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 86: 1121.
29. Chen, W., Sulcove, J., Frank, I., Jaffer, S., Ozdener, H. and Kolson, D.L., 2002, Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway. J. Virol. 76: 9407.
30. Choi, D.W., 1988, Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623.
31. Choi, D.W., Koh, J.Y. and Peters, S., 1988a, Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 8: 185.
32. Choi, D.W., Yokoyama, M. and Koh, J., 1988b, Zinc neurotoxicity in cortical cell culture. Neuroscience 24: 67.
33. Choi, Y.B., Tenneti, L., Le, D.A., Ortiz, J., Bai, G., Chen, H.S. and Lipton, S.A., 2000, Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat. Neurosci. 3: 15.
34. + modulation of the NMDA receptor. J. Neurosci. 21: 392.
35. Clifford, D.B., 1999, Central neurologic complications of HIV infection. Curr. Infect. Dis. Rep. 1: 187.
36. + T cells. Science 270: 1811.
37. Conant, K., Garzino-Demo, A., Nath, A., McArthur, J.C., Halliday, W., Power, C., Gallo, R.C. and Major, E.O., 1998, Induction of monocyte chemoattractant protein-1 in HIV-1 Tat- stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA 95: 3117.
38. Cunningham, P.H., Smith, D.G., Satchell, C., Cooper, D.A. and Brew, B., 2000, Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS 14: 1949.
39. Das, S., Sasaki, Y.F., Rothe, T., Premkumar, L.S., Takasu, M., Crandall, J.E., Dikkes, P., Conner, D.A., Rayudu, P.V., Cheung, W., Chen, H.S., Lipton, S.A. and Nakanishi, N., 1998, Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3a. Nature 393: 377.
40. Dawson, V.L., Dawson, T.M., London, E.D., Bredt, D.S. and Snyder, S.H., 1991, Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88: 6368.
41. Dawson, V.L., Dawson, T.M., Bartley, D.A., Uhl, G.R. and Snyder, S.H., 1993, Mechanisms of nitric oxidemediated neurotoxicity in primary brain cultures. J. Neurosci. 13: 2651.
42. De Clercq, E., 2004, HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches. Int. J. Biochem. Cell Biol. 36: 1800.
43. Digicaylioglu, M. and Lipton, S.A., 2001, Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signaling cascades. Nature 412: 641.
44. Digicaylioglu, M., Garden, G., Timberlake, S., Fletcher, L. and Lipton, S.A., 2004a, Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 101: 9855.
45. Digicaylioglu, M., Kaul, M., Fletcher, L., Dowen, R. and Lipton, S.A., 2004b, Erythropoietin protects cerebrocortical neurons from HIV-1/gp120-induced damage. Neuroreport 15: 761.
46. Doble, A., 1999, The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol. Ther. 81: 163.
47. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381: 667.
48. Dreyer, E.B. and Lipton, S.A., 1995, The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur. J. Neurosci. 7: 2502.
49. Dreyer, E.B., Kaiser, P.K., Offermann, J.T. and Lipton, S.A., 1990, HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248: 364.
50. Elkabes, S., DiCicco-Bloom, E.M. and Black, I.B., 1996, Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16: 2508.
51. Ellis, R.J., Deutsch, R., Heaton, R.K., Marcotte, T.D., McCutchan, J.A., Nelson, J.A., Abramson, I., Thal, L.J., Atkinson, J.H., Wallace, M.R. and Grant, I., 1997, Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch. Neurol. 54: 416.
52. Erdo, S.L. and Schafer, M., 1991, Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate. Eur. J. Pharmacol. 198: 215.
53. Everall, I.P., Heaton, R.K., Marcotte, T.D., Ellis, R.J., McCutchan, J.A., Atkinson, J.H., Grant, I., Mallory, M. and Masliah, E., 1999, Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC group. HIV Neurobehavioral Research Center. Brain Pathol. 9: 209.
54. Fiala, M., Looney, D.J., Stins, M., Way, D.D., Zhang, L., Gan, X., Chiappelli, F., Schweitzer, E.S., Shapshak, P., Weinand, M., Graves, M.C., Witte, M. and Kim, K.S., 1997, TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol. Med. 3: 553.
55. Fontana, G., Valenti, L. and Raiteri, M., 1997, gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons. J. Neurosci. Res. 49: 732.
56. Fox, L., Alford, M., Achim, C., Mallory, M. and Masliah, E., 1997, Neurodegeneration of somatostatinimmunoreactive neurons in HIV encephalitis. J. Neuropathol. Exp. Neurol. 56: 360.
57. Galasso, J.M., Harrison, J.K. and Silverstein, F.S., 1998, Excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats. Am. J. Pathol. 153: 1631.
58. Garaci, E., Caroleo, M.C., Aloe, L., Aquaro, S., Piacentini, M., Costa, N., Amendola, A., Micera, A., Calio, R., Perno, C.F. and Levi-Montalcini, R., 1999, Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc. Natl. Acad. Sci. USA 96: 14013.
59. Garden, G.A., Guo, W., Jayadev, S., Tun, C., Balcaitis, S., Choi, J., Montine, T.J., Moller, T. and Morrison, R.S., 2004, HIV associated neurodegeneration requires p53 in neurons and microglia. FASEB J. 18: 1141.
60. Gartner, S., 2000, HIV infection and dementia. Science 287: 602.
61. Gelbard, H.A., Dzenko, K.A., DiLoreto, D., del Cerro, C., del Cerro, M. and Epstein, L.G., 1993, Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev. Neurosci. 15: 417.
62. Gelbard, H.A., Nottet, H.S., Swindells, S., Jett, M., Dzenko, K.A., Genis, P., White, R., Wang, L., Choi, Y.B., Zhang, D. et al., 1994, Platelet-activating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68: 4628.
63. Gelbard, H.A., James, H.J., Sharer, L.R., Perry, S.W., Saito, Y., Kazee, A.M., Blumberg, B.M., and Epstein, L.G., 1995, Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol. Appl. Neurobiol. 21: 208.
64. Gendelman, H.E., Persidsky, Y., Ghorpade, A., Limoges, J., Stins, M., Fiala, M. and Morrisett, R., 1997, The neuropathogenesis of the AIDS dementia complex. AIDS 11 suppl A: S35.
65. Gendelman, H.E., Grant, I., Lipton, S.A., Everall, I. and Swindells, S., 2005, The Neurology of AIDS. Oxford University Press, London.
66. Giulian, D., Vaca, K. and Noonan, C.A., 1990, Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250: 1593.
67. Giulian, D., Wendt, E., Vaca, K. and Noonan, C.A., 1993, The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. USA 90: 2769.
68. Giulian, D., Yu, J., Li, X., Tom, D., Li, J., Wendt, E., Lin, S.N., Schwarcz, R. and Noonan, C., 1996, Study of receptor-mediated neurotoxins released by HIV-1 infected mononuclear phagocytes found in human brain. J. Neurosci. 16: 3139.
69. Glass, J.D., Wesselingh, S.L., Selnes, O.A. and McArthur, J.C., 1993, Clinical-neuropathologic correlation in HIVassociated dementia. Neurology 43: 2230.
70. Glass, J.D., Fedor, H., Wesselingh, S.L. and McArthur, J.C., 1995, Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38: 755.
71. Gleichmann, M., Gillen, C., Czardybon, M., Bosse, F., Greiner-Petter, R., Auer, J. and Muller, H.W., 2000, Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur. J. Neurosci. 12: 1857.
72. Gonzalez, E., Rovin, B.H., Sen, L., Cooke, G., Dhanda, R., Mummidi, S., Kulkarni, H., Bamshad, M.J., Telles, V., Anderson, S.A., Walter, E.A., Stephan, K.T., Deucher, M., Mangano, A., Bologna, R., Ahuja, S.S., Dolan, M.J. and Ahuja, S.K., 2002, HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc. Natl. Acad. Sci. USA 99: 13795.
73. Gonzalez-Scarano, F. and Martin-Garcia, J., 2005, The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5: 69.
74. Gonzalez-Zulueta, M., Feldman, A.B., Klesse, L.J., Kalb, R.G., Dillman, J.F., Parada, L.F., Dawson, T.M. and Dawson, V.L., 2000, Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc. Natl. Acad. Sci. USA 97: 436.
75. Gras, G., Chretien, F., Vallat-Decouvelaere, A.V., Le Pavec, G., Porcheray, F., Bossuet, C., Leone, C., Mialocq, P., Dereuddre-Bosquet, N., Clayette, P., Le Grand, R., Creminon, C., Dormont, D., Rimaniol, A.C. and Gray, F., 2003, Regulated expression of sodium-dependent glutamate transporters and synthetase: a neuroprotective role for activated microglia and macrophages in HIV infection? Brain Pathol. 13: 211.
76. He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Busciglio, J., Yang, X., Hofmann, W., Newman, W., Mackay, C.R., Sodroski, J. and Gabuzda, D., 1997, CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645.
77. Hesselgesser, J., Taub, D., Baskar, P., Greenberg, M., Hoxie, J., Kolson, D.L. and Horuk, R., 1998, Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr. Biol. 8: 595.
78. Heyes, M.P., Brew, B.J., Martin, A., Price, R.W., Salazar, A.M., Sidtis, J.J., Yergey, J.A., Mouradian, M.M., Sadler, A.E., Keilp, J., Rubinow, D. and Markey, S.P., 1991, Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29: 202.
79. Ho, D.D., Rota, T.R., Schooley, R.T., Kaplan, J.C., Allan, J.D., Groopman, J.E., Resnick, L., Felsenstein, D., Andrews, C.A. and Hirsch, M.S., 1985, Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N. Engl. J. Med. 313: 1493.
80. Jain, K.K., 2000, Evaluation of memantine for neuroprotection in dementia. Expert. Opin. Investig. Drugs 9: 1397.
81. Jiang, Z.G., Piggee, C., Heyes, M.P., Murphy, C., Quearry, B., Bauer, M., Zheng, J., Gendelman, H.E. and Markey, S.P., 2001, Glutamate is a mediator of neurotoxicity in secretions of activated HIV- 1-infected macrophages. J. Neuroimmunol. 117: 97.
82. Johnston, J.B., Jiang, Y., van Marle, G., Mayne, M.B., Ni, W., Holden, J., McArthur, J.C. and Power, C., 2000, Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity. J. Virol. 74: 7211.
83. Jones, G. and Power, C., 2006, Regulation of neural cell survival by HIV-1 infection. Neurobiol. Dis. 21: 1.
84. Kalams, S.A. and Walker, B.D., 1995, Cytotoxic T lymphocytes and HIV-1 related neurologic disorders. Curr. Top. Microbiol. Immunol. 202: 79.
85. Kaul, M., 2002, Chemokines and their receptors in HIV-associated dementia. J. Neurovirol. 8 suppl. 1: 41.
86. Kaul, M. and Lipton, S.A., 1999, Chemokines and activated macrophages in gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96: 8212.
87. Kaul, M., Garden, G.A. and Lipton, S.A., 2001, Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988.
88. Kaul, M., Zheng, J., Okamoto, S., Gendelman, H.E. and Lipton, S.A., 2005, HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 12 suppl. 1: 878.
89. Kaul, M., Ma, Q., Medders, K.E., Desai, M.K. and Lipton, S.A., 2006, HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. July 14; [Epub ahead of print].
90. Keilhoff, G. and Wolf, G., 1992, Memantine prevents quinolinic acid-induced hippocampal damage. Eur. J. Pharmacol. 219: 451.
91. Kerr, S.J., Armati, P.J., Pemberton, L.A., Smythe, G., Tattam, B. and Brew, B.J., 1997, Kynurenine pathway inhibition reduces neurotoxicity of HIV-1- infected macrophages. Neurology 49: 1671.
92. Kikuchi, M., Tenneti, L. and Lipton, S.A., 2000, Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J. Neurosci. 20: 5037.
93. Kim, W.K., Choi, Y.B., Rayudu, P.V., Das, P., Asaad, W., Arnelle, D.R., Stamler, J.S. and Lipton, S.A., 1999, Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-. Neuron 24: 461.
94. Koenig, S., Gendelman, H.E., Orenstein, J.M., Dal Canto, M.C., Pezeshkpour, G.H., Yungbluth, M., Janotta, F., Aksamit, A., Martin, M.A. and Fauci, A.S., 1986, Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089.
95. Kohr, G., Eckardt, S., Luddens, H., Monyer, H. and Seeburg, P.H., 1994, NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron 12: 1031.
96. Kramer-Hammerle, S., Rothenaigner, I., Wolff, H., Bell, J.E. and Brack-Werner, R., 2005, Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 111: 194.
97. Krathwohl, M.D. and Kaiser, J.L., 2004a, Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 22: 109.
98. Krathwohl, M.D. and Kaiser, J.L., 2004b, HIV-1 promotes quiescence in human neural progenitor cells. J. Infect. Dis. 190: 216.
99. Kullander, K., Kylberg, A. and Ebendal, T., 1997, Specificity of neurotrophin-3 determined by loss-of-function mutagenesis. J. Neurosci. Res. 50: 496.
100. Langford, D., Sanders, V.J., Mallory, M., Kaul, M. and Masliah, E., 2002, Expression of stromal cell-derived factor 1alpha protein in HIV encephalitis. J. Neuroimmunol. 127: 115.
101. +]i homeostasis and induce neurotoxicity in human embryonic neurons. Eur. J. Neurosci. 7: 2285.
102. Lapidot, T. and Petit, I., 2002, Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30: 973.
103. Lavi, E., Kolson, D.L., Ulrich, A.M., Fu, L. and Gonzalez-Scarano, F., 1998, Chemokine receptors in the human brain and their relationship to HIV infection. J. Neurovirol. 4: 301.
104. Lazarov-Spiegler, O., Solomon, A.S., Zeev-Brann, A.B., Hirschberg, D.L., Lavie, V. and Schwartz, M., 1996, Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J. 10: 1296.
105. Le, D.A. and Lipton, S.A., 2001, Potential and current use of N-methyl-D-aspartate (NMDA) receptor antagonists in diseases of aging. Drugs Aging 18: 717.
106. Le, D., Das, S., Wang, Y.F., Yoshizawa, T., Sasaki, Y.F., Takasu, M., Nemes, A., Mendelsohn, M., Dikkes, P., Lipton, S.A. and Nakanishi, N., 1997, Enhanced neuronal death from focal ischemia in AMPA-receptor transgenic mice. Brain Res. Mol. Brain Res. 52: 235.
107. Lees, K.R., 1997, Cerestat and other NMDA antagonists in ischemic stroke. Neurology 49: S66.
108. Lei, S.Z., Pan, Z.H., Aggarwal, S.K., Chen, H.S., Hartman, J., Sucher, N.J. and Lipton, S.A., 1992, Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8: 1087.
109. Letendre, S.L., Lanier, E.R. and McCutchan, J.A., 1999, Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1. J. Infect. Dis. 180: 310.
110. Lipton, S.A., 1992a, Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 42: 1403.
111. Lipton, S.A., 1992b, Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci. 15: 75.
112. Lipton, S.A., 1992c, Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuroreport 3: 913.
113. Lipton, S.A., 1993, Prospects for clinically tolerated NMDA antagonists: open- channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16: 527.
114. Lipton, S.A., 1994, HIV coat protein gp120 induces soluble neurotoxins in culture medium. Neurosci. Res. Commun. 15: 31.
115. Lipton, S.A., 1997a, Neuropathogenesis of acquired immunodeficiency syndrome dementia. Curr. Opin. Neurol. 10: 247.
116. Lipton, S.A., 1997b, Treating AIDS dementia [letter; comment]. Science 276: 1629.
117. Lipton, S.A., 1998, Neuronal injury associated with HIV-1: approaches to treatment. Annu. Rev. Pharmacol. Toxicol. 38: 159.
118. Lipton, S.A., 2004, Erythropoietin for neurologic protection and diabetic neuropathy. N. Engl. J. Med. 350: 2516.
119. Lipton, S.A. and Gendelman, H.E., 1995, Seminars in Medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332: 934.
120. Lipton, S.A. and Jensen, F.E., 1992, Memantine, a clinically-tolerated NMDA open-channel blocker, prevents HIV coat protein-induced neuronal injury in vitro and in vivo. Soc. Neurosci. Abstr. 18: 757.
121. Lipton, S.A. and Kieburtz, K., 1998, Development of adjunctive therapies for the neurologic manifestations of AIDS: dementia and painful neuropathy. In: The Neurology of AIDS. H.E. Gendelman, S.A. Lipton, L.G. Epstein and S. Swindells, eds, Chapman and Hall, New York, pp. 377.
122. Lipton, S.A. and Rosenberg, P.A., 1994, Excitatory amino acids as a final common pathway for neurologic disorders [see comments]. N. Engl. J. Med. 330: 613.
123. Lipton, S.A. and Stamler, J.S., 1994, Actions of redox-related congeners of nitric oxide at the NMDA receptor. Neuropharmacology 33: 1229.
124. Lipton, S.A. and Wang, Y.F., 1996, NO-related species can protect from focal cerebral ischemia/reperfusion. In: Pharmacology of cerebral ischemia. J. Krieglstein, ed., Medpharm Scientific Publisher, Stuttgart, pp. 183.
125. Lipton, S.A., Sucher, N.J., Kaiser, P.K. and Dreyer, E.B., 1991, Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7: 111.
126. Lipton, S.A., Choi, Y.B., Pan, Z.H., Lei, S.Z., Chen, H.S., Sucher, N.J., Loscalzo, J., Singel, D.J. and Stamler, J.S., 1993, A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364: 626.
127. Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R., MacDonald, M.E., Stuhlmann, H., Koup, R.A. and Landau, N.R., 1996, Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiplyexposed individuals to HIV-1 infection. Cell 86: 367.
128. Liu, Y., Jones, M., Hingtgen, C.M., Bu, G., Laribee, N., Tanzi, R.E., Moir, R.D., Nath, A. and He, J.J., 2000, Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat. Med. 6: 1380.
129. Lo, T.M., Fallert, C.J., Piser, T.M. and Thayer, S.A., 1992, HIV-1 envelope protein evokes intracellular calcium oscillations in rat hippocampal neurons. Brain Res. 594: 189.
130. Locati, M. and Murphy, P.M., 1999, Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 50: 425.
131. Lopalco, L., Barassi, C., Paolucci, C., Breda, D., Brunelli, D., Nguyen, M., Nouhin, J., Luong, T.T., Truong, L.X., Clerici, M., Calori, G., Lazzarin, A., Pancino, G. and Burastero, S.E., 2005, Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin. J. Gen. Virol. 86: 339.
132. Luo, X., Carlson, K.A., Wojna, V., Mayo, R., Biskup, T.M., Stoner, J., Anderson, J., Gendelman, H.E. and Melendez, L.M., 2003, Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 60: 1931.
133. Ma, Q., Jones, D., Borghesani, P.R., Segal, R.A., Nagasawa, T., Kishimoto, T., Bronson, R.T. and Springer, T.A., 1998, Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA 95: 9448.
134. Marshall, D.C., Wyss-Coray, T. and Abraham, C.R., 1998, Induction of matrix metalloproteinase-2 in human immunodeficiency virus-1 glycoprotein 120 transgenic mouse brains. Neurosci. Lett. 254: 97.
135. Masliah, E., Ge, N., Achim, C.L., Hansen, L.A. and Wiley, C.A., 1992, Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51: 585.
136. Masliah, E., Heaton, R.K., Marcotte, T.D., Ellis, R.J., Wiley, C.A., Mallory, M., Achim, C.L., McCutchan, J.A., Nelson, J.A., Atkinson, J.H. and Grant, I., 1997, Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC group. The HIV Neurobehavioral Research Center. Ann. Neurol. 42: 963.
137. Mattson, M.P., Haughey, N.J. and Nath, A., 2005, Cell death in HIV dementia. Cell Death Differ. 12: 893.
138. McArthur, J.C., Hoover, D.R., Bacellar, H., Miller, E.N., Cohen, B.A., Becker, J.T., Graham, N.M., McArthur, J.H., Selnes, O.A., Jacobson, L.P. et al., 1993, Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43: 2245.
139. McArthur, J.C., McClernon, D.R., Cronin, M.F., Nance-Sproson, T.E., Saah, A.J., St Clair, M. and Lanier, E.R., 1997, Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann. Neurol. 42: 689.
140. McArthur, J.C., Haughey, N., Gartner, S., Conant, K., Pardo, C., Nath, A. and Sacktor, N., 2003, Human immunodeficiency virus-associated dementia: an evolving disease. J. Neurovirol. 9: 205.
141. McGrath, K.E., Koniski, A.D., Maltby, K.M., McGann, J.K. and Palis, J., 1999, Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev. Biol. 213: 442.
142. Melton, S.T., Kirkwood, C.K. and Ghaemi, S.N., 1997, Pharmacotherapy of HIV dementia. Ann. Pharmacother. 31: 457.
143. Mennicken, F., Maki, R., de Souza, E.B. and Quirion, R., 1999, Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol. Sci. 20: 73.
144. Meucci, O. and Miller, R.J., 1996, Gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J. Neurosci. 16: 4080.
145. Meucci, O., Fatatis, A., Simen, A.A., Bushell, T.J., Gray, P.W. and Miller, R.J., 1998, Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95: 14500.
146. Michael, N.L. and Moore, J.P., 1999, HIV-1 entry inhibitors: evading the issue [news] [see comments]. Nat. Med. 5: 740.
147. Miller, R.J. and Meucci, O., 1999, AIDS and the brain: Is there a chemokine connection? Trends Neurosci. 22: 471.
148. Milligan, C.E., Cunningham, T.J. and Levitt, P., 1991, Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain. J. Comp. Neurol. 314: 125.
149. Minghetti, L., 2005, Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 18: 315.
150. Miwa, T., Furukawa, S., Nakajima, K., Furukawa, Y. and Kohsaka, S., 1997, Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J. Neurosci. Res. 50: 1023.
151. Mukherjee, P.K., DeCoster, M.A., Campbell, F.Z., Davis, R.J. and Bazan, N.G., 1999, Glutamate receptor signaling interplay modulates stress- sensitive mitogen-activated protein kinases and neuronal cell death. J. Biol. Chem. 274: 6493.
152. Muller, W.E., Schroder, H.C., Ushijima, H., Dapper, J. and Bormann, J., 1992, Gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur. J. Pharmacol. 226: 209.
153. Nath, A., 1999, Pathobiology of human immunodeficiency virus dementia. Semin. Neurol. 19: 113.
154. Nath, A., Psooy, K., Martin, C., Knudsen, B., Magnuson, D.S., Haughey, N. and Geiger, J.D., 1996, Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70: 1475.
155. Navia, B.A., Dafni, U., Simpson, D., Tucker, T., Singer, E., McArthur, J.C., Yiannoutsos, C., Zaborski, L. and Lipton, S.A., 1998, A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology 51: 221.
156. Nicholas, R.S., Stevens, S., Wing, M.G. and Compston, D.A., 2002, Microglia-derived IGF-2 prevents TNFalpha induced death of mature oligodendrocytes in vitro. J. Neuroimmunol. 124: 36.
157. Nicotera, P., Ankarcrona, M., Bonfoco, E., Orrenius, S. and Lipton, S.A., 1997, Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neurol. 72: 95.
158. Nottet, H.S., Jett, M., Flanagan, C.R., Zhai, Q.H., Persidsky, Y., Rizzino, A., Bernton, E.W., Genis, P., Baldwin, T., Schwartz, J., LaBenz, C.J. and Gendelman, H.E., 1995, A regulatory role for astrocytes in HIV-1 encephalitis.
159. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154: 3567.
160. Nottet, H.S., Persidsky, Y., Sasseville, V.G., Nukuna, A.N., Bock, P., Zhai, Q.H., Sharer, L.R., McComb, R.D., Swindells, S., Soderland, C. and Gendelman, H.E., 1996, Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 156: 1284.
161. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J.L., Arenzana-Seisdedos, F., Schwartz, O., Heard, J. M., Clark-Lewis, I., Legler, D.F., Loetscher, M., Baggiolini, M. and Moser, B., 1996, The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382: 833.
162. Ohagen, A., Ghosh, S., He, J., Huang, K., Chen, Y., Yuan, M., Osathanondh, R., Gartner, S., Shi, B., Shaw, G. and Gabuzda, D., 1999, Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J. Virol. 73: 897.
163. Olney, J.W., 1969, Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164: 719.
164. Olney, J.W. and Sharpe, L.G., 1969, Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science 166: 386.
165. Osborne, N.N. and Quack, G., 1992, Memantine stimulates inositol phosphates production in neurones and nullifies N-methyl-D-aspartate-induced destruction of retinal neurons. Neurochem. Int. 21: 329.
166. Parsons, C.G., Danysz, W. and Quack, G., 1999, Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist-a review of preclinical data. Neuropharmacology 38: 735.
167. Paxton, W.A., Martin, S.R., Tse, D., O'Brien, T.R., Skurnick, J., VanDevanter, N.L., Padian, N., Braun, J.F., Kotler, D.P., Wolinsky, S.M. and Koup, R.A., 1996, Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med. 2: 412.
168. + lymphocytes from exposed- uninfected individuals: Association with low expression of CCR5 and high production of beta-chemokines. Virology 244: 66.
169. Pellegrini, J.W. and Lipton, S.A., 1993, Delayed administration of memantine prevents N-methyl-D- aspartate receptor-mediated neurotoxicity. Ann. Neurol. 33: 403.
170. Persidsky, Y., Stins, M., Way, D., Witte, M.H., Weinand, M., Kim, K.S., Bock, P., Gendelman, H.E. and Fiala, M., 1997, A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J. Immunol. 158: 3499.
171. Petito, C.K. and Roberts, B., 1995, Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146: 1121.
172. Petito, C.K., Cho, E.S., Lemann, W., Navia, B.A. and Price, R.W., 1986, Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol. Exp. Neurol. 45: 635.
173. Pierson, T.C., Doms, R.W. and Pohlmann, S., 2004, Prospects of HIV-1 entry inhibitors as novel therapeutics. Rev. Med. Virol. 14: 255.
174. Pittaluga, A., Pattarini, R., Severi, P. and Raiteri, M., 1996, Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120. AIDS 10: 463.
175. Power, C., McArthur, J.C., Nath, A., Wehrly, K., Mayne, M., Nishio, J., Langelier, T., Johnson, R.T. and Chesebro, B., 1998, Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J. Virol. 72: 9045.
176. Power, C., Gill, M.J. and Johnson, R.T., 2002, Progress in clinical neurosciences: the neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy. Can. J. Neurol. Sci. 29: 19.
177. Prospero-Garcia, O., Gold, L.H., Fox, H.S., Polis, I., Koob, G.F., Bloom, F.E. and Henriksen, S.J., 1996, Microgliapassaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys. Proc. Natl. Acad. Sci. USA 93: 14158.
178. Rapalino, O., Lazarov-Spiegler, O., Agranov, E., Velan, G.J., Yoles, E., Fraidakis, M., Solomon, A., Gepstein, R., Katz, A., Belkin, M., Hadani, M. and Schwartz, M., 1998, Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4: 814.
179. Robinson, A.P., White, T.M. and Mason, D.W., 1986, Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunol. 57: 239.
180. Rottman, J.B., Ganley, K.P., Williams, K., Wu, L., Mackay, C.R. and Ringler, D.J., 1997, Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 151: 1341.
181. Ryan, L.A., Zheng, J., Brester, M., Bohac, D., Hahn, F., Anderson, J., Ratanasuwan, W., Gendelman, H.E. and Swindells, S., 2001, Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. J. Infect. Dis. 184: 699.
182. Sardar, A.M., Hutson, P.H. and Reynolds, G.P., 1999, Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS. Neuroreport 10: 3513.
183. Sasseville, V.G., Newman, W., Brodie, S.J., Hesterberg, P., Pauley, D. and Ringler, D.J., 1994, Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/alpha 4 beta 1 integrin interactions. Am. J. Pathol. 144: 27.
184. Sathi, S., Edgecomb, P., Warach, S., Manchester, K., Donaghey, T., Stieg, P.E., Jensen, F.E. and Lipton, S.A., 1993, Chronic transdermal nitroglycerin (NTG) is neuroprotective in experimental rodent stroke models. Soc. Neurosci. Abstr. 19: 849.
185. Sattler, R., Xiong, Z., Lu, W.Y., Hafner, M., MacDonald, J.F. and Tymianski, M., 1999, Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284: 1845.
186. Savio, T. and Levi, G., 1993, Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J. Neurosci. Res. 34: 265.
187. Scala, E., D'Offizi, G., Rosso, R., Turriziani, O., Ferrara, R., Mazzone, A.M., Antonelli, G., Aiuti, F. and Paganelli, R., 1997, C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J. Immunol. 158: 4485.
188. Schifitto, G., Sacktor, N., Marder, K., McDermott, M.P., McArthur, J.C., Kieburtz, K., Small, S. and Epstein, L.G., 1999, Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium. Neurology 53: 391.
189. Seif el Nasr, M., Peruche, B., Rossberg, C., Mennel, H.D. and Krieglstein, J., 1990, Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur. J. Pharmacol. 185: 19.
190. Stieg, P.E., Sathi, S., Warach, S., Le, D.A. and Lipton, S.A., 1999, Neuroprotection by the NMDA receptorassociated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat. Eur. J. Pharmacol. 375: 115.
191. Stumm, R.K., Rummel, J., Junker, V., Culmsee, C., Pfeiffer, M., Krieglstein, J., Hollt, V. and Schulz, S., 2002, A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4- dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J. Neurosci. 22: 5865.
192. Sullivan, J.M., Traynelis, S.F., Chen, H.S., Escobar, W., Heinemann, S.F. and Lipton, S.A., 1994, Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron 13: 929.
193. Susman, E., 2001, Memantine improves function and cognition in advanced Alzheimer's. Inpharma Weekly 1292: 5.
194. Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S., Kishimoto, T. and Nagasawa, T., 1998, The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393: 591.
195. Tenneti, L., D'Emilia, D.M. and Lipton, S.A., 1997, Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci. Lett. 236: 139.
196. Tenneti, L., D'Emilia, D.M., Troy, C.M. and Lipton, S.A., 1998, Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J. Neurochem. 71: 946.
197. Toggas, S.M., Masliah, E., Rockenstein, E.M., Rall, G.F., Abraham, C.R. and Mucke, L., 1994, Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188.
198. Toggas, S.M., Masliah, E. and Mucke, L., 1996, Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res. 706: 303.
199. Tornatore, C., Chandra, R., Berger, J.R. and Major, E.O., 1994, HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44: 481.
200. Tran, P.B. and Miller, R.J., 2003, Chemokine receptors: signposts to brain development and disease. Nat. Rev. Neurosci. 4: 444.
201. Turchan, J., Sacktor, N., Wojna, V., Conant, K. and Nath, A., 2003, Neuroprotective therapy for HIV dementia. Curr. HIV. Res. 1: 373.
202. Turrin, N.P. and Rivest, S., 2004, Unraveling the molecular details involved in the intimate link between the immune and neuroendocrine systems. Exp. Biol. Med. (Maywood. ) 229: 996.
203. UNAIDS., 2004, Report on the global AIDS epidemic; executive summary.
204. Verani, A. and Lusso, P., 2002, Chemokines as natural HIV antagonists. Curr. Mol. Med. 2: 691.
205. + permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration. Trends Neurosci. 23: 365.
206. Welch, K. and Morse, A., 2002, The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy. AIDS Patient. Care STDS. 16: 75.
207. Wesselingh, S.L., Takahashi, K., Glass, J.D., McArthur, J.C., Griffin, J.W. and Griffin, D.E., 1997, Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J. Neuroimmunol. 74: 1.
208. Wiley, C.A., Soontornniyomkij, V., Radhakrishnan, L., Masliah, E., Mellors, J., Hermann, S.A., Dailey, P. and Achim, C.L., 1998, Distribution of brain HIV load in AIDS. Brain Pathol. 8: 277.
209. Yeh, M.W., Kaul, M., Zheng, J., Nottet, H.S., Thylin, M., Gendelman, H.E. and Lipton, S.A., 2000, Cytokinestimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of L - cysteine. J. Immunol. 164: 4265.
210. Zagury, D., Lachgar, A., Chams, V., Fall, L.S., Bernard, J., Zagury, J.F., Bizzini, B., Gringeri, A., Santagostino, E., Rappaport, J., Feldman, M., O'Brien, S.J., Burny, A. and Gallo, R.C., 1998, C-C chemokines, pivotal in protection against HIV type 1 infection. Proc. Natl. Acad. Sci. USA 95: 3857.
211. Zhang, L., He, T., Talal, A., Wang, G., Frankel, S.S. and Ho, D.D., 1998, In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J. Virol. 72: 5035.
212. Zhang, K., McQuibban, G.A., Silva, C., Butler, G.S., Johnston, J.B., Holden, J., Clark-Lewis, I., Overall, C.M. and Power, C., 2003, HIV-induced metalloproteinase processing of the chemokine stromal cell-derived factor-1 causes neurodegeneration. Nat. Neurosci. 6: 1064.
213. Zhao, J., Lopez, A.L., Erichsen, D., Herek, S. Cotter, R.L., Curthoys, N.P. and Zheng, J., 2004a, Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: Linkage to HIV-1 associated dementia. J. Neurochem. 88: 169.
214. Zhao, M.L., Si, Q. and Lee, S.C., 2004b, IL-16 expression in lymphocytes and microglia in HIV-1 encephalitis. Neuropathol. Appl. Neurobiol. 30: 233.
215. Zheng, J., Thylin, M.R., Ghorpade, A., Xiong, H., Persidsky, Y., Cotter, R., Niemann, D., Che, M., Zeng, Y.C., Gelbard, H.A., Shepard, R.B., Swartz, J.M. and Gendelman, H.E., 1999, Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 98: 185.
216. Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I. and Littman, D.R., 1998, Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595